Azgp1

Uses your system voice; voice and rate in settings.

Q24406451Snapshot

≈ 4 min read

Names in other languages

  • DeutschAzgp1
  • EnglishAzgp1
  • EspañolAzgp1
  • FrançaisAzgp1
  • NederlandsAzgp1
  • PortuguêsAzgp1
  • srnAzgp1
  • SvenskaAzgp1

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Zinc-alpha-2-glycoprotein is a protein that in humans is encoded by the AZGP1 gene. AZGP1, also referred to as zinc-alpha-2-glycoprotein (ZAG), is a glycoprotein with a molecular weight of 38-40 kDa. In 1961, AZGP1 was initially isolated from normal human plasma and named as ZAG due to its distinctive electrophoretic mobility within the alpha-2 region and its ability to bind to zinc. Subsequent analysis further identified its specific location on a particular chromosome on chromosome 7q22.1 by fluorescence in situ hybridization.

AZGP1 is widely expressed in various tissues and body fluids, including the breast, stomach, liver, prostate, plasma, urine, and saliva. This gene expresses a soluble protein that stimulates lipolysis, induces a reduction in body fat in mice, is associated with the cachexia related to cancer, and is known to be expressed in secretory cells of lung epithelium. In 2009, it was found that smoking increases expression of this gene, which is why smoking cessation leads to weight gain. Decreased circulating AZGP1 levels are associated with diabetes 2.

AZGP1 has been identified as a biomarker in cancer patients, with its role varying depending on the specific type of cancer. Low expression of AZGP1 is correlated with unfavorable outcomes in gastric cancer, esophageal squamous cell carcinoma, liver cancer, bladder cancer, and prostate cancer.…

Zinc-alpha-2-glycoprotein is a protein that in humans is encoded by the AZGP1 gene. AZGP1, also referred to as zinc-alpha-2-glycoprotein (ZAG), is a glycoprotein with a molecular weight of 38-40 kDa. In 1961, AZGP1 was initially isolated from normal human plasma and named as ZAG due to its distinctive electrophoretic mobility within the alpha-2 region and its ability to bind to zinc. Subsequent analysis further identified its specific location on a particular chromosome on chromosome 7q22.1 by fluorescence in situ hybridization.

AZGP1 is widely expressed in various tissues and body fluids, including the breast, stomach, liver, prostate, plasma, urine, and saliva. This gene expresses a soluble protein that stimulates lipolysis, induces a reduction in body fat in mice, is associated with the cachexia related to cancer, and is known to be expressed in secretory cells of lung epithelium. In 2009, it was found that smoking increases expression of this gene, which is why smoking cessation leads to weight gain. Decreased circulating AZGP1 levels are associated with diabetes 2.

AZGP1 has been identified as a biomarker in cancer patients, with its role varying depending on the specific type of cancer. Low expression of AZGP1 is correlated with unfavorable outcomes in gastric cancer, esophageal squamous cell carcinoma, liver cancer, bladder cancer, and prostate cancer. For example, AZGP1 is a potential biomarker for predicting surgical failure and negatively regulates angiogenesis in prostate cancer. Elevated levels of AZGP1 have been significantly associated with poor overall survival and disease-free survival in colon cancer.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330138530 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot azgp1-2746060-38cbe74d25b0d58d · hash 38cbe74d25b0d58d2172d4d3098d27d03dedba10ad189782295321ad8aeaaaf9 · captured 1767027586.0 · version history

Cite this page as: encyclopegia.org, “Azgp1”, snapshot azgp1-2746060-38cbe74d25b0d58d. https://encyclopegia.org/a/azgp1

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.